Latest Breaking News On - Amanda sellersverge scientific communications - Page 1 : comparemela.com

Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting

Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDanielj hicklinExchange commissionCrohn colitis foundationCenters for diseaseCompany contactAmanda sellersverge scientific communicationsCompany or werewolf nasdaqCompany formDevelopment of conditionally activeAmerican association of immunologistsWerewolf therapeutics incFirst data demonstrating applicationAmerican associationChief executive officerDisease control

Werewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR 2024 Annual Meeting

Werewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR 2024 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoDanielj hicklinWerewolf therapeutics incCompany contactExchange commissionAmanda sellersverge scientific communicationsCompany or werewolf nasdaqAmerican association for cancer researchAmerican associationCancer researchAnnual meetingChief executive officerPoster sectionNon hodgkin lymphomaNote regarding forward looking statementsthis

Werewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual Meeting

Werewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDanielj hicklinAmanda sellersverge scientific communicationsCompany contactAmerican association of immunologistsCompany or werewolf nasdaqExchange commissionWerewolf therapeutics incWerewolf therapeuticsAmerican associationChief executive officerSession dateNon hodgkin lymphomaNote regarding forward looking statementsthisPrivate securities litigation reform actJosh rappaportstern